Target intelligence / Profile preview

Pre-proinsulin peptide–HLA-A*02:01 complex

Molecular classification
Ligand–MHC class I antigen complex, Immune complex
01

Overview

The pre-proinsulin peptide–HLA-A*02:01 complex is a molecular complex formed by the binding of an epitope from human preproinsulin (commonly the 3–11 region, such as LWMRLLPLL) to the HLA-A*02:01 major histocompatibility complex class I molecule. This complex is presented on the surface of cells (notably pancreatic beta cells) and can be specifically recognized by CD8+ T cell receptors. In type 1 diabetes, autoreactive cytotoxic T cells target these complexes, leading to immune-mediated destruction of insulin-producing beta cells. The complex represents a key autoimmune target and is a central mechanistic component in the pathogenesis of type 1 diabetes[2][4]. Molecular mimicry with microbial peptides may also break immune tolerance, contributing to disease initiation[4]. Key considerations: - This entry describes a peptide–MHC (major histocompatibility complex) complex, not a traditional 'single protein' drug target like a receptor or enzyme. It is, however, the functional epitope recognized by pathogenic T cells in type 1 diabetes[2][4]. - Therapeutic strategies (including engineered T cell receptors, immune tolerance induction, or peptide-based immunomodulation) may target this complex, but there are no approved drugs directly targeting it[2][4]. - As a peptide–MHC complex, it is highly relevant in immunology and autoimmunity research, but not typically considered a canonical pharmacological molecular target (hence is_incorrect: true). If you require a strictly canonical protein target (like "Insulin" or "HLA-A*02:01"), the above entry is too complex/specific as given. If you require antigen/MHC complexes driving T cell responses, this entry is relevant but does not fit standardized molecular target databases.

Other names
Preproinsulin 3–11–HLA-A*02:01 complexPPI 3–11–HLA-A*02:01 complexPreproinsulin peptide–HLA class I complexHLA-A*02:01 preproinsulin complexPPI–HLA-A*02 complex
02

Mechanism of action

T cell recognition (CD8+ cytotoxic T lymphocyte activation via recognition of the complex by T cell receptor)

03

Biological functions

Antigen presentationImmune responseT cell activation
04

Disease associations

AutoimmunityType 1 diabetes
05

Safety considerations

Potential for off-target cytotoxicity (autoimmunity if cross-reactive)Risk of breaking tolerance (therapeutic targeting could provoke autoimmunity)
06

Biomarkers

Presence of CD8+ T cells recognizing the PPI–HLA complex as a biomarker for islet autoimmunity in type 1 diabetes

Beyond the preview

Go deeper on Pre-proinsulin peptide–HLA-A*02:01 complex.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-proinsulin peptide–HLA-A*02:01 complex.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call